Restricted accessResearch articleFirst published online 2006-2
Comparison between Site N-Category and Number N-Category for Nodal Staging in Carcinoma of the Gastroesophageal Junction: Our Experience and Literature Review
Gastroesophageal junction (GEJ) neoplasms have become more common over the past decade. Like mediastinal and abdominal lymph nodes and other gastric tumors, GEJ tumors spread to the retroperitoneal nodes. The TNM staging system does not consider this pattern and does not clinically distinguish GEJ tumors from gastric and esophageal cancers. The aim of the study is to compare the old and new TNM staging systems to assess whether the new TNM classifies lymph node involvement in these tumors as a prognostic factor. From January 1983 to December 1995, 438 patients underwent curative gastric resections for cancer at the Department of Surgery “P. Valdoni” of the University of Rome “La Sapienza.” Sixty-two had GEJ type II and III tumors according to the Siewert classification system. The old pN1 and new pN1 survival rates (P < 0.05) were statistically different; the old pN2 and new pN2 survival rates (P = 0.483) were not. The multivariate analysis of significant statistical prognostic factors showed that the pTNM staging in type II and type III GEJ tumors is the most important prognostic factor (P < 0.001), followed by the old pN and new pN (P < 0.001) and the pT (P < 0.005). Gender, age, Lauren type, and tumor location according to Siewert (II vs III) were not independently significant prognostic factors. This study concludes that the numbers and locations of metastatic lymph nodes are important prognostic factors that should be included in the next TNM edition.
WaymanJ., FormanD., GriffinS.M.Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry.Cancer Causes Control2001; 12: 943–9.
3.
DolanK., SuttonR., WalkerS.J., MorrisA.I., CampbelF., WilliamsE.M.New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology.Br J Cancer1999; 80: 834–42.
4.
KocherH.M., LinklaterK., PatelS., EllulJ.P.Epidemiological study of oesophageal and gastric cancer in southeast England.Br J Surg2001; 88: 1249–57.
5.
CorleyD.A., BufflerP.A.Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database.Int J Epidemiol2001; 30: 1415–25.
6.
RuchV.W.Are cancers of the esophagus, gastroesophageal junction, and cardia one disease, two, or several?Semin Oncol2004; 31: 444–9.
7.
SharmaP.Cancer of the esophagogastric junction: epidemiology and pathogenesis.J Gastrointest Surg2002; 6: 516–7.
8.
DevesaS.S., FraumeniJ.F.Jr.The rising incidence of gastric cardia cancer.J Natl Cancer Inst1999; 91: 747–9.
9.
BlotW.J., DevesaS.S., KnellerR.W., FraumeniJ.F.Jr.Rising incidence of adenocarcinoma of the esophagus and gastric cardia.JAMA1991; 265: 1287–9.
10.
YeW., ChowW.H., LagergrenJ., YinL., NyrenO.Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery.Gastroenterology2001; 121: 1286–93.
11.
CorvalanA., KoriyamaC., AkibaS.Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile.Int J Cancer2001; 94: 527–30.
12.
FukayamaM., ChongJ.M., UozakiH.Pathology and molecular pathology of Epstein-Barr virus-associated gastric carcinoma.Curr Top Microbiol Immunol2001; 258: 91–102.
13.
SiewertJ.R., SteinH.J.Classification of adenocarcinoma of the oesophagogastric junction.Br J Surg1998; 85: 1457–9.
14.
SteupW.H., De LeynP., DeneffeG.Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification.J Thorac Cardiovasc Surg1996; 111: 85–94; discussion 94–5.
15.
AikouT., NatugoeS., TenabeG.Lymph drainage originating from the lower esophagus and gastric cardia as measured by radioisotope uptake in the regional lymph nodes following lymphoscintigraphy.Lymphology1987; 20: 145–51.
16.
de ManzoniG., PedrazzaniC., Di LeoA.Metastases to the paraaortic lymph nodes in adenocarcinoma of the cardia.Eur J Surg2001; 167: 413–8.
17.
KataiH., YoshimuraK., MaruyamaK.Evaluation of the new International Union Against Cancer TNM staging for gastric carcinoma.Cancer2000; 88: 1796–800.
18.
FujiiK., IsozakiH., OkajimaK.Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system.Br J Surg1999; 86: 685–9.
19.
YooC.H., NohS.H., KimY.I., MinJ.S.Comparison of prognostic significance of nodal staging between old (4th edition) and new (5th edition) UICC TNM classification for gastric carcinoma. International Union Against Cancer.World J Surg1999; 23: 492–7; discussion 497–8.
RamacciatoG., AurelloP., D'AngeloF.Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?Hepato-Gastroenterology2000; 47: 1470–4.
24.
Japanese Gastric Cancer Association.The new Japanese classification of gastric carcinoma (2nd English Ed.).Gastric Cancer1998; 1: 1–15.
25.
VolpeC.M., KooJ., MilordS.M.The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.J Am Coll Surg1995; 181: 56–64.
26.
DresnerS.M., LambP.J., BennettM.K.The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction.Surgery2001; 129: 103–9.
27.
KaplanE.L., MeyerP.Nonparametric estimates for incomplete observations.J Am Stat Assoc1958; 53: 456–81.
28.
CoxD.R.Regression models and life tables.J R Stat Soc B1972; 34: 187–220.
29.
PeraM.Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction.Recent Results Cancer Res2000; 155: 1–14.
30.
FeinM., FuchsK.H., RitterM.P.Application of the new classification for cancer of the cardia.Surgery1998; 124: 707–14.
SiewertJ.R., BummR.Adenocarcinoma of the esophagogastric junction. IGCA Consensus Conference; 1997 April 27–30; Munich.
33.
SiewertJ.R., FeithM., WernerM., SteinH.J.Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients.Ann Surg2000; 232: 353–61.
34.
SiewertJ.R., SteinH.J.Adenocarcinoma of the gastroesophageal junction: classification, pathology and extent of resection.Dis Esoph1996; 9: 173–82.
35.
BonenkampJ.J.Surgery for upper gastrointestinal malignancies.Semin Oncol2004; 31: 542–53.
36.
AbdallaE.K., PistersP.W.T.Staging and preoperative evaluation of upper gastrointestinal malignancies.Semin Oncol2004; 31: 513–29.
37.
KarpehM.S., LeonL., KlimstraD., BrennanM.F.Lymph node staging in gastric cancer: is location more important than number?An analysis of 1,038 patients Ann Surg.2000; 232: 362–71.
38.
de ManzoniG., PedrazzaniC., VerlatoG.Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastroesophageal junction.Br J Surg2004; 91: 296–303.
39.
WaymanJ., BennettM.K., RaimesS.A., GriffinS.M.The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction.Br J Cancer2002; 86: 1223–9.
40.
KoderaY., YamamuraY., ShimizuY.Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert's classification applied to 177 cases resected at a single institution.J Am Coll Surg1999; 189: 594–601.
